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Abstract. A single donor surgeon's experience pro-
curing the livers from 132 donors is described. 
Thirty-seven grafts (28.9%) had hepatic arterial 
anomalies, 19 (14.4%) of which required arterial 
reconstruction prior to transplantation. Of the 121 
grafts evaluated for early function, 103 grafts 
(85.2%) functioned well, whereas 14 grafts (11.6%) 
functioned poorly and 4 grafts (3.3%) failed to 
function at all. The variables associated with less 
than optimal function of the graft consisted of 
donor age (P< 0.05), duration of donor's stay in 
the intensive care unit (P < 0.005), abnormal graft 
appearance (P < 0.05), and such recipient problems 
as vascular thromboses during or immediately fol-
lowing transplantation (P < 0.005). A new preserva-
tion fluid, University of Wisconsin solution, 
allowed safe and longer cold storage of the liver 
allograft than did Euro-Collins' solution 
(P < 0.0001). A parameter of liver allograft viability, 
which is simple and predictive of allograft function 
prior to the actual transplant procedure, is urgently 
needed. 
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Enormous progress has been achieved during the 
last 25 years since the first orthotopic liver transplan-
tation (OLTx) was performed in humans in 1963. 
With improvements in the overall outcome of the re-
cipients, OLTx has established its role as a therapeu-
tic option for patients with end-stage liver disease [3, 
20, 22]. For this major surgical procedure to succeed, 
however, it is essential that the liver allograft 
functions immediately. Primary graft nonfunction 
remains a dreadful complication of OLTx, one that 
is associated with a high mortality and morbidity 
[18]. Our previous study on donor selection and the 
clinical outcome of OLTx, however, demonstrated a 
poor correlation between all presently available 
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donor parameters and the early outcome of OLTx 
[13]. The approach that most transplant centers cur-
rently take to procuring liver allografts seems to 
involve the delegation of surgeons who are experi-
enced in the field of organ procurement and to 
whom the final assessment of the quality of the graft 
is assigned. In this report, the personal experience of 
132 allograft hepatectomies by a single surgeon is 
analyzed in order to identify the role of a number of 
variables pertinent to the clinical outcome of 0 L Tx. 
Materials and methods 
During the 21-month period between 29 January 1987 and 1 Sep-
tember 1988, 132 allograft hepatectomies were performed by a 
single donor surgeon (K. Y.). Of these, 128 livers (97%) were trans-
planted orthotopically to a total of 119 patients with end-stage 
liver disease at the University of Pittsburgh Health Center. The 
other 4 livers were not transplanted and were, therefore, excluded 
from the study. In three cases this was due to the poor quality of 
the graft, which had multiple liver lacerations (as a result of a 
motor vehicle accident), possible portal vein thrombosis, and fatty 
liver associated with size discrepancy from the recipient liver. In 
another case there was a major size discrepancy, the allograft liver 
from a 2-day-old neonate being too small for the only remaining 
recipient. All donors were brain dead and all but five were heart-
beating cadavers. In these five grafts, unexpected cardiac arrest 
occurred immediately before or during procurement of the liver, 
and cardiopulmonary resuscitation was performed. The age of the 
donors varied from 3 months to 48 years, with a mean of 
23.8 years. Seventy-nine (61.7%) of the donors were male. Table 1 
lists the causes of death of the donors. All donors were located in 
North America, 124 in the United States and 4 in Canada (Fig. 1). 
Donor selection criteria 
Patients who might potentially have transmitted any disease were 
excluded from consideration as organ donors. Because of the ab-
sence of a correlation between the traditional parameters of donor 
assessment and the early outcome of OLTx in the previous study 
[13], no rigid criteria were established for donor selection. Instead, 
selection was primarily made on an individual basis, depending 
upon the condition of the potential recipient. In general, donors 
were selected who were less than 50 years of age, who had no his-
tory of liver disease such as hepatitis or alcoholism, and who had 
a total serum bilirubin less than 2.0 mg/ dl, normal or near-normal 
SGOT, SGPT, and prothrombin time, and an adequate arterial 
blood gas. Elevations of SGOT or SGPT, with a tendency to 
decline, were not regarded as a contraindication for donation of 
the liver. 
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Donor maintenance 
Donors were fluid-resuscitated once they had been pronounced 
brain dead in order to maintain a central venous pressure of 
8-10 em H20 and urine output over 1 mllkg per hour as a guide. 
For donors receiving vasopressin for diabetes insipidus, the vaso-
pressin was discontinued as soon as possihle to avoid liver ische-
mia secondary to a decreased splanchnic blood flow. Urine output 
was replaced vigorously with intravenous fluids, usually one-half 
or quarter normal saline solution with potassium chloride. Elec-
trolytes were checked frequently, especially to correct hypokale-
mia. Normothermia was maintained with a thermoblanket. 
Ninety-two donors (71.9%) required vasopressor support. Do-
pamine was the primary choice since it is known to preserve 
splanchnic blood flow [6, 16]. The use of pure alpha stimulators, 
such as norepinephrine hitartrate (Levophed), was avoided. Blood 
was transfused to maintain the hematocrit above 300,1" in order to 
maintain adequate oxygen delivery to the tissues. 
Operative technique 
The technique of allograft hepatectomy involved both rapid per-
fusion and modified rapid perfusion. 
Table 1. Causes of brain death among 128 liver donors 
Cause N 
Trauma 89 (69.5%) 
Motor vehicle accident 60 
Fall 6 
Gunshot wound 19 
Other 4 
Cerebrovascular accident 20 (15.6%) 
Subarachnoid hemorrhage 19 
Cerebral infarct 1 
Other 19 (14.8%) 
Anoxic brain damage 11 
Brain tumor 2 
Cerebral embolism 1 
Bacterial meningitis 2 
Unknown 3 
Total 128 (100%) 
Fig. 1. Location of the donors 
Rapid perfusion technique (n =60). This technique has been de-
scribed in detail elsewhere [23]. Briefly, both the terminal aorta 
and the inferior mesenteric vein were dissected to insert aortic and 
portal perfusion cannulae. The supraceliac abdominal aorta was 
encircled and crossclamped. Following cardiectomy, dissection of 
the liver hilum was performed in a bloodless field. Following 
identification in the retropancreatic portion, the right side of the 
superior mesenteric artery (SMA) was dissected toward the aorta, 
searching for an aberrant right hepatic artery (HA) originating 
from the SMA. A Carrel patch of aorta was excised, with care not 
to injure the origin of the renal arteries. This has been our 
preferred method of hepatectomy in children or unstable donors, 
or in cases of extreme urgency when the recipient is in fulminant 
liver failure due to fulminant hepatitis or graft nonfunction fol-
lowing OLTx. 
Modified rapid perfusion technique (n = 68). This differs from the 
rapid perfusion technique in that dissection of the liver hilum oc-
curs prior to crossclamping of the aorta and cannulation of the dis-
tal splenic vein with a larger caliber catheter for a quicker portal per-
fusion. This preliminary dissection allows more selective and rapid 
cooling of the liver than does the rapid perfusion technique. These 
additional preparatory steps required 30-45 min. This technique 
has been our choice for stable adult donors and for donors whose 
livers are of a questionable quality. During the preparatory dissec-
tion, changes in the color or consistency of the allograft were ob-
served in response to diuresis, better oxygenation, or bowel rest fol-
lowing extensive renal dissection by a kidney team. 
Method of organ preservation 
First, 49 livers were harvested using in situ perfusion with lactated 
Ringer's or Euro-Collins' solution (4°C). This was followed by ex 
vivo flush with Euro-Collins' solution (4°C). Thereafter, the livers 
were preserved by ex vivo perfusion at the back table with Univer-
sity of Wisconsin (UW) solution (4°C) [1]. 
Technique of vascular reconstruction 
for arterial anomalies 
Arterial reconstruction of the liver graft is req uired prior to trans-
plantation if a common arterial channel is absent due to an anom-
aly. The most common arterial anomaly requiring reconstruction 
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was the aberrant right HA arising from the SMA, for which an 
end-to-end anastomosis was performed between the distal donor 
splenic artery and the proximal aberrant right HA. This was 
achieved with a Carrel patch of the SMA, obviating a small caliber 
anastomosis [9]. Care was taken to avoid an inadvertent anasto-
mosis with rotation. The continuous suture technique with 7-0 
monofilament polypropolene (Prolene), as described by Starzl et 
al. [21], was used for the reconstruction. Just before the sutures 
were tied, the reconstructed HA was allowed to distend by pul-
satile infusion of cold solution while the distal HA was occluded 
digitally. With the application of "growth factor" principle [21] to 
the ex vivo condition, this method facilitated migration of Prolene 
sutures into the anastomosis and allowed secure anastomosis 
without leakage or stricture. 
Classification of the early graft function 
Early graft function in the recipients who survived the transplant 
procedure (121 grafts, 112 patients) was classified as good, fair, 
poor, or graft nonfunction, according to the poorest category into 
which any of the parameters fell (Table 2). Graft nonfunction was 
defined as the inability of the graft to sustain the metabolic 
homeostasis of a recipient during the 1st postoperative week, 
presenting with the clinical manifestations of grade III or IV 
coma, coagulopathy with prothrombin time over 20 s, high SGOT 
and SGPT values, renal failure, and progressive or persistent 
hyperbilirubinemia, resulting in retransplantation of the graft or 
death of the recipient. 
Analysis of the correlation between the donor 
or allograft variables and early graft function 
I n order to analyze the significance of the donor or allograft fac-
tors on the quality of grafts harvested by a single donor surgeon, 
the donor or allograft variables were analyzed in relation to the 
early graft function of 109 grafts in 102 patients who survived the 
operative procedure and who did not develop intraoperative or 
immediately postoperative complications that adversely affected 
the quality of the grafts. The exclusion of 19 patients (15.7%) was 
due to intraoperative mortality from hemorrhage during 
hepatectomy due to technical difficulties (n =6), intraoperative 
cardiac failure due to cardiomyopathy (n = 1), HA thrombo-
sis (n = 6), severe HA stenosis (n = 1), portal vein thrombo-
sis (n = 2), severe pancreatitis (n =2), and prolonged warm ische-
mia during the revision of the suprahepatic caval anastomosis 
after initial revascularization (n = 1). None of the grafts excluded 
from the analysis of early graft function was attributed or thought 
to have contributed to the development of the problems described 
above. 
High dose vasopressors were defined as dopamine of over 
10 ~g/kg per minute or additional alpha stimulators. The appear-
Table 2. Criteria for the classification of early graft function. 
GNFN, Graft nonfunction: FFP, fresh frozen plasma 
Variable 
SGOT(IU/I) 
SGPT(lu/I) 
FFP requirement 
Early graft function 
Good 
< 1500 
< 1000 
No 
Fair 
1500-3500 
1000-2500 
No 
Poor 
> 3500 
> 2500 
Yes 
GNFN a 
a Defined as the inability of the liver allograft to sustain the meta-
bolic homeostasis of the recipient 
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Table 3. Vascular reconstruction for hepatic arterial anomalies. 
RHA, Right hepatic artery; SMA, superior mesenteric artery; 
SpA. splenic artery; LHA, left hepatic artery; CA. celiac axis; 
PHA. proper hepatic artery 
Anomaly n 
Aberrant RHA 14 (10.9%) 
from SMA 13 
from aorta 
Aberrant LHA 16 (13.3%) 
from CA 14 
from aorta 3 
Aberrant RHA 6b (5U/rl) 
and LHA 
RHAfrom SMA 
LHAfrom CA 
Total 37 (28.9%) 
a Both were missing the PHA 
b One was missing the PHA 
Method of reconstruction (n) 
Donor SpA to aberrant RHA (10) 
Aortic fold-over (1) 
Nonea (2) 
Donor SpA to aberrant RHA (1) 
None (14) 
Donor SpA to PHA (1) 
None (2) 
Donor SpA to RHA (5) 
CA to distal SMA (1) 
Table 4. Early graft function after orthotopic liver transplanta-
tion. GNFN, Graft nonfunction. * P< 0.005 (Xc = 12.81) when 
good/fair and poor/nonfunction were compared between recip-
ients with and without problems 
Early graft Number of recipient problems Total 
function 
No Yesa 
Good 74 (67.9%) 4 (33.3%) 78 (64.5%) 
Fair 23(21.1%) 2 (16.7%) 25 (20.7%) 
Poor 6 (8.3%) 5 (41.7%) 14 (11.6%) 
GNFN 3 (3.5%) 1 (8.3%) 4(3.3%) 
Total 109 (100%) 12 (100%) 121 (100%) 
a Consists of hepatic artery thrombosis in 7, portal vein throm-
bosis in 2, severe pancreatitis in 2, and prolonged warm ischemia 
in one patient 
ance of the graft was classified as abnormal when the liver either 
felt firm or exhibited discoloration. 
Statistical analyses 
Student's t- and chi-square tests were used for the statistical evalu-
ation of the data. 
Results 
Vascular anomalies 
Table 3 lists the incidence of hepatic arterial anom-
alies and various methods of arterial reconstruction. 
Hepatic arterial anomalies were present in 37 grafts 
(28.9%): the aberrant right HA in 14 (10.9°11), the 
aberrant left HA in 17 (13.3%), and both aberrant 
right and left hepatic arteries in 6 grafts (5%). Of 
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Table 5. Correlation between donor or graft variables and early 
graft function. CIT, Cold ischemia time; T. Bil, total bilirubin 
Variable Early graft function 
Good Fair Poor Nonfunction 
(n=74) (n=23) (n=9) (n=3) 
Age (years)' b 19.9± 10.9 22.2±8.6 25.8± 12.8 32.3 ± 9.3 
Sex (M:F) 46:28 16:7 7:2 1:2 
Cause of death 
Motor vehicle 
accident (n = 55) 35 (63.6%) 13 (23.6%) 6 (10.9%) 1 (1.8%) 
Subarachnoid 
hemorrhage 
(n = 15) 11 (73.3%) 1 (6.7%) 2 (13.3%) 1 (6.7%) 
Gunshot wound 
(n = 15) 12 (80%) 2 (13.3%) 1 (6.7%) 0 
Anoxia (n = 7) 5 (71.4%) 2 (28.6%) 0 0 
Other (n = 17) 11 (64.7%) 4 (23.5%) 1 (5.9%) 1 (5.9%) 
Lab data 
SGOT (lUll)' 78.7 ± 58.1 60.3 ± 37.9 101.2±68.9 70±81.5 
SGPT (lU/I)' 43.5±33.1 61 ± 55.1 68.6±44 36±20.9 
T.BiI (mg/dl)' 0.75±OA 0.81 ±0.39 0.61 ±OA2 1.1 ±0.79 
PT (s)' 15.6±1.7 13A± 1.65 13±1.1 12.6±0.9 
ICU stay (days)' C 3.7 ±2.7 5.7±2.7 5.8± 1.7 3.3 ± 1.5 
CPR 13 (19.4%) 3 (16.7%) 0 0 
High dose 
vasopressors 28 (37.8%) 7 (30.8%) 2 (22.2%) 0 
Instability during 
procurement 16 (21.6%) 2 (8.7%) 2 (22.2%) 2(66.7%) 
Abnormal graft 
appearancedd 18 (25.7%) 5 (21.7%) 5 (55.6%) 1 (33.3%) 
Technique 
(rapid:modified) 30:44 6:17 1:8 0:3 
CIT (min)' 499 ± 206 624±349 473±229 357±95 
aMean±SD 
b P< 0.05 when grafts with good/fair and poor/nonfunction are 
compared 
C P< 0.005 when grafts with good and fair/poor function are 
compared 
d P< 0.05 (X2 = 4.29) when grafts with good/fair and poor func-
tion are compared 
these, 19 grafts (51.4%) required vascular reconstruc-
tion at the back table in order to construct a common 
arterial channel. One (5.3%) ofthe anastomoses con-
structed at the back table required the revision due to 
rotation, but none became the cause of postoperative 
HA thrombosis. 
Complications 
A total offour complications (3.1%) occurred during 
or after allograft hepatectomy: aortic rupture while 
encircling the supraceliac abdominal aorta prior to 
crossclamping, inadvertent transection of the aber-
rant right HA, once originating directly from the 
aorta and once from the left side of the SMA, and 
avulsion injury of the origin of the splenic artery of a 
pediatric liver during dissection of the HA at the 
back table. The aortic rupture necessitated rapid 
removal of organs from the donor. All of the grafts 
harvested from that donor (heart, liver, and kidneys) 
functioned well in the recipients. The transected 
aberrant right hepatic arteries were reconstructed 
using end-to-end anastomosis with the donor splenic 
artery, as in other cases, without any difficulty. The 
avulsion injury of the origin of the splenic artery was 
repaired with interrupted 8-0 Prolene sutures, and 
the HA remained patent postoperatively. Overall, 
none of the complications affected the outcome of 
the liver or other organ recipients. 
Early graft function 
Table 4 lists the early graft function of the 121 allo-
grafts after OLTx. Graft function was good or fair in 
97 out of 109 (89%) of the grafts without recipient 
problems, whereas as many as 6 out of 12 (50%) of 
the grafts with recipient problems during or immedi-
ately following OLTx exhibited poor or nonfunction 
(P< 0.005; X2 =12.81). Table 5 shows the correla-
tion between the donor or graft variables and the 
early graft function of the 109 grafts in 102 patients 
who survived the operation and who did not develop 
the aforementioned recipient complications during 
or immediately following OLTx. A statistically sig-
nificant difference was demonstrated in donor age, 
duration of patient's stay in the intensive care unit, 
and the presence of abnormal graft appearance. The 
donors of grafts with poor or nonfunction were sig-
nificantlyyounger than those with good or fair func-
tion (P< 0.05). Furthermore, the donors of grafts 
with fair or poor function stayed in the intensive care 
unit longer than those with good function 
(P < 0.005), and the grafts with abnormal appear-
ance were associated with a higher incidence of fair 
or poor graft function in recipients (P < 0.05; 
X2 = 4.29). On the other hand, no definitive correla-
tion with early graft function was observed in sex, re-
sults of liver function tests, cause of death, require-
ment of cardiopulmonary resuscitation or infusion 
of high-dose vasopressors, donor instability during 
procurement, or cold ischemia time. 
Effect of preservation solution on early graft function 
Of the 109 grafts analyzed in relation to early graft 
function, 39 were preserved in Euro-Collins' solution 
and 70 in UW solution (Table 6). Grafts preserved in 
UW solution had a significantly longer cold ischemia 
time than those stored in Euro-Collins' solution 
(P< 0.0001). However, as shown in Table 7, no statis-
tical difference between the two groups was seen in the 
early liver function of the grafts. 
Table 6. Comparison of preservation fluids and cold ischemia 
time. UW, University of Wisconsin solution; * P < 0.0001 
Preservation fluid Preservation time (min) 
Minimum Maximum Mean ± SD* 
Euro-Collins (n = 39) 240 
UW (n = 70) 282 
472 
1320 
348± 67 
561±304 
Table 7. Comparison of preservation fluids and early graft func-
tion. UW, University of Wisconsin solution 
Preservation Early graft function 
fluid 
Good Fair Poor Nonfunction 
(n = 74) (n=23) (n =9) (n=3) 
Euro-Collins 
(n = 39) 25 (64.1%) 10 (25.6%) 3 (7.7%) 1 (2.6%) 
UW (n=70) 49 (70%) 13 (18.6%) 6 (8.6%) 2 (2.9%) 
Recipient survival 
Of the 112 patients who received 121 liver allografts, 
89 patients with 92 grafts (79.5%) survived and were 
discharged; their follow-up period ranged from 1 to 
21 months (mean 5.3 months). Of these, 87 patients 
with 90 grafts (77.7%) remain alive and well. 
Discussion 
In this report, 132 liver allografts harvested by a 
single surgeon were analyzed. The donor or allograft 
variables pertinent to early graft function in this 
series were the age of the donor, duration of the 
donor's stay in the intensive care unit, and abnormal 
appearance of the graft. 
The effect of increased donor age on the outcome 
of solid organ transplantation remains controversial. 
For cadaveric kidney transplantation, O'Connor et 
al. [15] reported in 1986 that kidney grafts from do-
nors over 55 years of age achieved primary graft 
function and i-year graft survival comparable to 
those from younger donors. Hong et al. [8] in 1981 
and Foster et a1. [5] in 1988, on the other hand, de-
scribed a significantly lower incidence of immediate 
function and i-year graft survival in cadaver allo-
grafts from donors over 50 years of age. Generally 
speaking, the upper age limit for the liver is arbitrari-
ly set at 50 [28]. Aging creates morphological and 
functional alterations in the liver [4, 27] and has been 
reported to be a discriminating factor in liver re-
generation [17]. In liver surgery, on the other hand, 
chronological age does not seem to adversely affect 
the outcome of hepatic resection [29]. Our current 
approach towards the older donor consists of judi-
cious selection, especially in older donors with a his-
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tory of circulatory arrest of hemodynamic instability, 
based on the assumption that hepatic reserve is re-
duced with aging. 
As to the hemodynamic stability of the donor, hy-
potension or the requirement of high-dose dopamine 
has been associated with nonfunction or delayed 
function, respectively, of kidney grafts [7, 14]. Al-
though no obvious harmful effects of cardiopulmon-
ary resuscitation or of the requirement of high-dose 
vasopressors on the early function of the liver allo-
graft were demonstrated in this study, these parame-
ters strongly suggest suboptimal perfusion of the 
liver and warm ischemic injury. Since the success of 
OLTx is dependent on immediate function of the 
graft, we continue to apply cautious selection to do-
nors with these variables. 
As to the abnormal appearance of the graft, little is 
known about the correlation between gross appear-
ance and quality of the graft. Livers from donors with 
diabetes insipidus, who have been on vasopressin for 
a prolonged period of time, are often firm and suggest 
the presence of ischemic injury. Since the use of vaso-
pressin has been associated with a marked reduction 
in the blood flow to the liver [6], donors scheduled for 
liver procurement should be taken off vasopressin as 
soon as possible in order to minimize ischemic dam-
age. Overhydration can distend the liver by an in-
crease in central venous pressure and give a false im-
pression as to the consistency of the liver. In our 
experience, the central venous pressure reading in the 
operating room is often unreliable. If the liver is dis-
tended from overhydration, the administration of in-
travenous diuretics or, ifthe donor has severe diabetes 
insipidus, simple discontinuation of intravenous 
fluids usually softens the liver. 
The other significant factor related to early mal-
function of the liver allograft was recipient problems 
during or immediately following OLTx, consisting 
mainly of vascular complications. The liver is a very 
vascular organ with a rich and complicated blood 
supply, and vascular complications during or after 
OLTx can easily ruin an optimal graft [12, 26]. 
Preservation of the integrity of the HA, while 
avoiding injury to renal arteries, is one of the impor-
tant tasks of a donor surgeon. Intimal dissection of the 
donor artery has been reported as a cause of HA 
thrombosis, presumably due to inadvertent traction 
on the artery [2, 11], and accidental transection of the 
aberrant arterial branches necessitates a vascular re-
pair or manipulation of the small caliber arteries, 
which can lead to the development of dreaded HA 
thrombosis. The aberrant right HA arising from the 
SMA is by far the most common arterial anomaly re-
quiring reconstruction prior to transplantation. Pal-
pation of the posterior surface of the hepatoduodenal 
ligament before crossclamping of the aorta, however, 
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is not always a reliable maneuver to identify the aber-
rant right HA. In this series, routine dissection of the 
right side of the SMA before transection of the hepato-
duodenal ligament during allograft hepatectomy 
allowed for the preservation of the aberrant right HA 
originating from the SMA in all but one case. 
Recently, a breakthrough in the preservation of the 
liver allograft was achieved by Belzer et al. [1, 10]. Our 
experience with UW solution since October 1987 has 
confirmed the improved quality as well as safe prolon-
gation of the preservation time of liver grafts 
preserved in UW solution, as compared to grafts 
stored in Euro-Collins' solution [24]. The prolonga-
tion of preservation time allows for more secure he-
mostasis during recipient hepatectomy, and histologi-
cal evaluation of the graft prior to transplantation is 
now possible for grafts with steatosis [25]. 
For the assessment of organ viability in clinical 
OLTx, there is, to date, no practical and simple tech-
nique available that is discriminantly predictive of 
allograft function before the actual transplant proce-
dure [9]. Since primary graft nonfunction remains a 
major cause of mortality, and since the shortage of 
donor organs remains a major limiting factor in clini-
cal liver transplantation [10, 18], the development of 
such a predictive parameter is urgently needed in 
order to reduce mortality and morbidity related to 
early malfunction of the liver allograft. 
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